Bezuclastinib

For research use only. Not for therapeutic Use.

  • CAT Number: I045117
  • CAS Number: 1616385-51-3
  • Purity: ≥95%
Inquiry Now

Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent activity against KIT D816V. Bezuclastinib can be used for the research of nonadvanced systemic mastocytosis (NonAdvSM)[1].
Bezuclastinib (25 mg/kg, p.o., 3 days) shows a brain:plasma ratio of 0.07 in rats[2].
Pharmacokinetic Analysis in Rats[2]

Route
Dose (mg/kg)
t1/2 (h)
Cmax (ng/mL)
AUClast (h*ng/mL)

p.o.
25
2.8
2592±364
21509±2558


Catalog Number I045117
CAS Number 1616385-51-3
Synonyms

4,5-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-3-carboxamide

Purity ≥95%
InChI InChI=1S/C19H17N5O/c1-11-12(2)23-24-17(11)19(25)21-15-8-14-9-16(22-18(14)20-10-15)13-6-4-3-5-7-13/h3-10H,1-2H3,(H,20,22)(H,21,25)(H,23,24)
InChIKey NVSHVYGIYPBTEZ-UHFFFAOYSA-N
SMILES CC1=C(NN=C1C(=O)NC2=CN=C3C(=C2)C=C(N3)C4=CC=CC=C4)C

Request a Quote